Health
Psychedelic drug discovery enabling discovery of new psychiatric drugs – Drug Target Review
Having resolved the structure of psychedelic drugs bound to the 5-HT2A serotonin receptor researchers are developing new therapeutic drugs.
Posted: 18 September 2020 | Hannah Balfour (Drug Target Review) | No comments yet
Having resolved the structure of psychedelic drugs bound to the 5-HT2A serotonin receptor researchers are now developing new therapeutic drugs.
Psychedelic drugs such as LSD, psilocybin, and mescaline cause severe and often long-lasting hallucinations, but also show great potential in treating serious psychiatric conditions, such as major depressive disorder. In order to understand their therapeutic effect, and p…
-
Noosa News12 hours agoTeenage girl dies in hit-and-run, police hunt for ute
-
Noosa News13 hours agoTeenage girl killed in alleged hit-and-run at Margate north of Brisbane
-
Noosa News7 hours agoArnie the dog found dead in stolen ute after week of searching
-
Noosa News6 hours ago‘Beyond devastated’ Brisbane family learn missing German shepherd Arnie found dead in back of stolen car